Health & Fitness
Health and Fitness
Health and Fitness
Thu, July 5, 2012
Wed, July 4, 2012
Tue, July 3, 2012
ViroPharma To Participate In The JMP Securities Healthcare Conference
ViroPharma To Participate In The JMP Securities Healthcare Conference -- EXTON, Pa., July 3, 2012 /PRNewswire/ --
ViroPharma To Participate In The JMP Securities Healthcare Conference
EXTON, Pa., July 3, 2012 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: [ VPHM ]) today announced that Colin Broom, MD, vice president and chief scientific officer of ViroPharma, will present at the 2012 JMP Securities Healthcare Conference at 11:00 A.M. ET on Thursday, July 12, 2012. The conference is being held at the Peninsula Hotel in New York City.
ViroPharma's presentations will be webcast live for investors through [ www.viropharma.com ] and available for a period of 14 days following the conferences.
About ViroPharma Incorporated ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet medical needs of patients living with diseases that have few if any clinical therapeutic options. ViroPharma is developing a portfolio of therapeutics for rare and Orphan diseases including C1 esterase inhibitor deficiency, Friedreich's Ataxia, and adrenal insufficiency; and recurrent C. difficile infection (CDI). Our goal is to provide rewarding careers to employees, to create new standards of care in the way serious diseases are treated, and to build international partnerships with the patients, advocates, and health care professionals we serve. ViroPharma's commercial products address diseases including hereditary angioedema (HAE), seizures and C. difficile-associated diarrhea (CDAD); for full U.S. prescribing information on our products, please download the package inserts at [ http://www.viropharma.com/Products.aspx ]; the prescribing information for other countries can be found at [ www.viropharma.com ].
ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, [ www.viropharma.com ]. The company encourages investors to consult these sections for more information on ViroPharma and our business.
SOURCE ViroPharma Incorporated
[ Back to top ] RELATED LINKS
[ http://www.viropharma.com ]
